D. Scott Neal’s GSK GSK Stock Holding History

D. Scott Neal’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$342K	Hold	7,928	–	–	0.16%	42
2025 Q2	$304K	Hold	7,928	–	–	0.15%	44
2025 Q1	$307K	Hold	7,928	–	–	0.17%	42
2024 Q4	$271K	Hold	7,928	–	–	0.15%	48
2024 Q3	$327K	Hold	7,928	–	–	0.17%	45
2024 Q2	$308K	Hold	7,928	–	–	0.17%	51
2024 Q1	$343K	Hold	7,928	–	–	0.22%	46
2023 Q4	$297K	Hold	7,928	–	–	0.26%	46
2023 Q3	$290K	Hold	7,928	–	–	0.25%	50
2023 Q2	$283K	Hold	7,928	–	–	0.21%	52
2023 Q1	$282K	Hold	7,928	–	–	0.16%	52
2022 Q4	$279K	Hold	7,928	–	–	0.14%	50
2022 Q3	$233K	Hold	7,928	–	–	0.1%	53
2022 Q2	$431K	Buy	7,928 +135	+2%	+$7.45K	0.18%	35
2022 Q1	$424K	Hold	7,793	–	–	0.17%	43
2021 Q4	$430K	Sell	7,793 -353	-4%	-$18.4K	0.16%	39
2021 Q3	$389K	Hold	8,146	–	–	0.16%	32
2021 Q2	$405K	Buy	+8,146	New	+$391K	0.18%	32
2016 Q4	–	Sell	-43	Closed	-$2K	–	170
2016 Q3	$2K	Hold	43	–	–	﹤0.01%	151
2016 Q2	$2K	Hold	43	–	–	﹤0.01%	157
2016 Q1	$2K	Buy	+43	New	+$2.14K	﹤0.01%	144

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D. Scott Neal's GSK Position: Q3 2025 in Review

D. Scott Neal held its GSK (GSK) position steady in Q3 2025 at 7,928 shares worth $342K. The position accounts for 0.16% of the portfolio, ranked #42.

D. Scott Neal first reported a position in GSK in Q1 2016 and has held it in 21 quarters since. The position peaked at $431K in Q2 2022. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

D. Scott Neal held 7,928 shares of GSK worth $342K as of Q3 2025.
D. Scott Neal left its GSK share count unchanged in Q3 2025.
GSK made up 0.16% of D. Scott Neal's portfolio in Q3 2025, its #42 holding.
D. Scott Neal first reported a position in GSK in Q1 2016 and has held it in 21 quarters since.
D. Scott Neal's GSK position peaked at $431K in Q2 2022.
895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on D. Scott Neal's 13F filing for Q3 2025, filed 28 Oct 2025.